Delivery Order SPE2DR25D1017-SPE2DR26F9BAP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,839 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on December 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,255.36 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,137.83 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, utilizes firm fixed pricing and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at...
- The Defense Logistics Agency awarded a delivery order valued at $2,004.14 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This competitive, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract, awarded on September 8, 2025, represents a non-competitive delivery order under an existing contract vehicle and is scheduled for completion by September 29, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $190,672.68 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on December 2, 2025, carries an ultimate completion date of December 23, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,212.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, competitively awarded contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,019.69 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on December 3, 2025, with completion scheduled for December 24, 2025. This firm fixed-price, non-set-aside delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BAPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,532.31 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on December 9, 2025, with a completion date of December 31, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated substantial capability in fulfilling competitive federal contracts across multiple therapeutic domains. The company's extensive federal contract portfolio with the DLA encompasses vaccines, specialty medications, brand-name and generic drugs, and specialized medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the company's ongoing role as a key supplier within the military medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/8/25 |